AI assistant
Sending…
Microbot Medical Inc. — Director's Dealing 2017
Sep 8, 2017
33819_dirs_2017-09-07_e6eb6b09-8e5a-4c18-b72a-dba6a287775e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2017-09-06
Reporting Person: Bornstein Yoseph (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-06 | Common Stock | S | 25000 | $1.00 | Disposed | 5245409 | Indirect |
| 2017-09-06 | Common Stock | S | 610 | $1.08 | Disposed | 5244799 | Indirect |
| 2017-09-06 | Common Stock | S | 20000 | $1.01 | Disposed | 5224799 | Indirect |
Footnotes
F1: Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. ("LSA") and of Shizim Ltd. ("Shizim"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities.
More from Microbot Medical Inc.
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 15
Earnings Release
2026
May 14
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 13